ArticleEuropean journal of clinical pharmacology2023

Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study.

Vladimir Trkulja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.